Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Ziege anti-Human IgG Antikörper (DyLight 680) - Preadsorbed

WB, FLISA, FM, DB Polyclonal IgG DyLight 680
Rockland
Produktnummer ABIN6698937
Hersteller Produkt- Nr.: 609-144-123

Kurzübersicht für Ziege anti-Human IgG Antikörper (DyLight 680) - Preadsorbed (ABIN6698937)

Target

IgG

Klonalität

  • 3028
  • 144
  • 6
  • 1
Polyklonal

Konjugat

  • 537
  • 362
  • 358
  • 283
  • 226
  • 203
  • 186
  • 109
  • 92
  • 71
  • 56
  • 55
  • 50
  • 50
  • 49
  • 44
  • 43
  • 40
  • 40
  • 39
  • 39
  • 39
  • 31
  • 30
  • 29
  • 29
  • 29
  • 29
  • 29
  • 29
  • 28
  • 27
  • 26
  • 26
  • 25
  • 25
  • 24
  • 22
  • 22
  • 22
  • 22
  • 22
  • 22
  • 22
  • 22
  • 21
  • 19
  • 17
  • 17
  • 17
  • 15
DyLight 680

Applikation

  • 1689
  • 1672
  • 1637
  • 1580
  • 919
  • 872
  • 753
  • 406
  • 345
  • 232
  • 232
  • 106
  • 87
  • 71
  • 57
  • 33
  • 24
  • 19
  • 18
  • 18
  • 16
  • 16
  • 12
  • 9
  • 8
  • 7
  • 7
  • 4
  • 4
  • 4
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), FLISA, Fluorescence Microscopy (FM), Dot Blot (DB)

Isotyp

IgG
  • Reaktivität

    • 613
    • 546
    • 531
    • 401
    • 344
    • 231
    • 186
    • 154
    • 130
    • 124
    • 109
    • 86
    • 84
    • 83
    • 82
    • 62
    • 48
    • 31
    • 28
    • 16
    • 15
    • 10
    • 5
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Human

    Wirt

    • 1490
    • 1364
    • 525
    • 208
    • 98
    • 83
    • 38
    • 29
    • 21
    • 20
    • 16
    • 11
    • 11
    Ziege

    Hersteller Produkt- Nr.

    609-144-123

    Hersteller

    Rockland

    Verwendungszweck

    Human IgG (H&L) Antibody DyLight™ 680 Conjugated Pre-Adsorbed

    Kreuzreaktivität (Details)

    Minimal crossreactivity against Bv Ch Gt GP Ham Hs Ms Rb Rt & Sh Serum Proteins

    Produktmerkmale

    Goat Anti Human IgG DyLight 680™ Conjugated Antibody, Goat Anti-Human IgG Antibody DyLight 680™ conjugation,Anti-Human IgG (H&L) DyLight 680 generated in goat detects human Immunoglobulin G (IgG), both heavy and light chains of the antibody molecule are present.

    Aufreinigung

    Preadsorption: Pre-Adsorbed

    Immunogen

    Human IgG whole molecule

    Labeling Ratio

    3.0
  • Applikationshinweise

    FLISA_Dilution: >1:20,000

    IF_Microscopy_Dilution: >1:5,000

    Western_Blot_Dilution: >1:10,000

    Other: User Optimized

    Kommentare

    Anti-Human IgG (H&L) DyLight 680 has been tested by dot blot and is designed for immunofluorescence microscopy, fluorescence based plate assays (FLISA) and fluorescent western blotting. This product is also suitable for multiplex analysis, including multicolor imaging, utilizing various commercial platforms. The emission spectra for this DyLight™ conjugate match the principle output wavelengths of most common fluorescence instrumentation.
    Suggested Applications: Microarray, WB

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Reconstitution Volume: 100 μL

    Reconstitution Buffer: Restore with deionized water (or equivalent)

    Konzentration

    1.0 mg/mL

    Buffer

    0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2, 10 mg/mL Bovine Serum Albumin (BSA) - Immunoglobulin and Protease free, 0.01 % (w/v) Sodium Azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store conjugated secondary antibody at 4° C prior to restoration. For extended storage aliquot contents and freeze at -20° C or below. Avoid cycles of freezing and thawing.  Centrifuge product if not completely clear after standing at room temperature. Conjugated Secondary Antibody is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.

    Haltbarkeit

    12 months
  • Russo, Unkauf, Meier, Wenzel, Langreder, Schneider, Wiesner, Bischoff, Stadler, Dübel: "In vitro evolution of myc-tag antibodies: in-depth specificity and affinity analysis of Myc1-9E10 and Hyper-Myc." in: Biological chemistry, Vol. 403, Issue 5-6, pp. 479-494, (2022) (PubMed).

    Edmiston, Jones, Vu, Ashwood, Van de Water: "Identification of the antigenic epitopes of maternal autoantibodies in autism spectrum disorders." in: Brain, behavior, and immunity, Vol. 69, pp. 399-407, (2019) (PubMed).

    Aliprandini, Takata, Lepique, Kalil, Boscardin, Moro: "An oligoclonal combination of human monoclonal antibodies able to neutralize tetanus toxin in vivo." in: Toxicon: X, Vol. 2, pp. 100006, (2019) (PubMed).

    Freire, Pol-Fachin, Coêlho, Viana, Magalhães, Cordeiro, Fischer, Loeffler, Jaenisch, Franca, Marques, Lins: "Mapping Putative B-Cell Zika Virus NS1 Epitopes Provides Molecular Basis for Anti-NS1 Antibody Discrimination between Zika and Dengue Viruses." in: ACS omega, Vol. 2, Issue 7, pp. 3913-3920, (2017) (PubMed).

    Mock, Warta, Geisenberger, Bischoff, Schulte, Lamszus, Stadler, Felgenhauer, Schichor, Schwartz, Matschke, Jungk, Ahmadi, Sahm, Capper, Glass, Tonn, Westphal, von Deimling, Unterberg, Bermejo et al.: "Printed peptide arrays identify prognostic TNC serumantibodies in glioblastoma patients. ..." in: Oncotarget, Vol. 6, Issue 15, pp. 13579-90, (2016) (PubMed).

  • Target

    IgG

    Substanzklasse

    Antibody

    Hintergrund

    It is a protein complex composed of four peptide chains - two identical heavy chains and two identical light chains arranged in a Y-shape typical of antibody monomers. Each IgG has two antigen binding sites. Representing approximately 75 % of serum immunoglobulins in humans, IgG is the most abundant antibody isotype found in the circulation. IgG molecules are synthesized and secreted by plasma B cells. Secondary Antibodies are available in a variety of formats and conjugate types. When choosing a secondary antibody product, consideration must be given to species and immunoglobulin specificity, conjugate type, fragment and chain specificity, level of cross-reactivity, and host-species source and fragment composition.
Sie sind hier:
Chat with us!